midazolam and clotrimazole

midazolam has been researched along with clotrimazole in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck, WT; Schuetz, EG; Schuetz, JD1
Fischer, H; Huwyler, J; Poli, S; Schwab, D; Tabatabaei, A1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Higashikawa, F; Kaneda, T; Murakami, T; Takano, M1
Badger, TM; Chen, Y; Jo, CH; Ronis, MJ; Simpson, P1
Baum, CL; Camp, JR; Chan, LN; Jeong, HY; Molokie, RE; Shord, SS; Vasquez, EM; Xie, H1

Reviews

1 review(s) available for midazolam and clotrimazole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for midazolam and clotrimazole

ArticleYear
Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Anti-Anxiety Agents; Antifungal Agents; Area Under Curve; Clotrimazole; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Midazolam; Middle Aged

2010

Other Studies

7 other study(ies) available for midazolam and clotrimazole

ArticleYear
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
    Molecular pharmacology, 1996, Volume: 49, Issue:2

    Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Northern; Cell Line; Clotrimazole; Colonic Neoplasms; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; DNA Primers; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Midazolam; Mixed Function Oxygenases; Molecular Sequence Data; Multigene Family; Phenobarbital; Phenytoin; Polymerase Chain Reaction; Rifampin; Tumor Cells, Cultured; Verapamil

1996
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
    Journal of medicinal chemistry, 2003, Apr-24, Volume: 46, Issue:9

    Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Drug Evaluation, Preclinical; Fluoresceins; Fluorescent Dyes; Humans; Indicators and Reagents; Mice; Models, Molecular; Rhodamines; Species Specificity; Swine

2003
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index

2014
In-vivo and in-vitro metabolic clearance of midazolam, a cytochrome P450 3A substrate, by the liver under normal and increased enzyme activity in rats.
    The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:4

    Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Aryl Hydrocarbon Hydroxylases; Clotrimazole; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dexamethasone; Enzyme Activation; In Vitro Techniques; Intestinal Mucosa; Liver; Male; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley; Substrate Specificity; Time Factors

1999
Diets containing soy protein isolate increase hepatic CYP3A expression and inducibility in weanling male rats exposed during early development.
    The Journal of nutrition, 2004, Volume: 134, Issue:12

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Base Sequence; Blotting, Northern; Clotrimazole; Cytochrome P-450 CYP3A; Dexamethasone; Dietary Proteins; DNA Probes; DNA, Complementary; Liver; Male; Midazolam; Oxidoreductases, N-Demethylating; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Soybean Proteins; Testosterone; Transcription, Genetic

2004